New Immunoassays in Therapeutic Drug Monitoring: Where is the Journey Heading?

Ther Drug Monit. 2023 Feb 1;45(1):11-13. doi: 10.1097/FTD.0000000000001048.

Authors

Salvatore J Salamone¹, Jodi B Courtney¹, William A Clarke²

Affiliations

¹ Saladax Biomedical, Inc., Bethlehem, Pennsylvania ; and.
² Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland .

PMID: 36191293
DOI: 10.1097/FTD.0000000000001048

No abstract available

MeSH terms

Cross Reactions
Drug Monitoring*
Humans
Immunoassay